Axsome Therapeutics, Inc. - Common Stock (AXSM) stock analysis

AXSM · Axsome Therapeutics, Inc. - Common Stock

Latest recorded price: USD 137.01

Sector and industry: Healthcare · Biotechnology

Fiscal 2025 figures: free cash flow margin -14.7%. The model flags 2 risk signals for this company (1 high severity).

Similar companies in Healthcare